Neurovascular Drug Biotransformation Machinery in Focal Human Epilepsies: Brain CYP3A4 Correlates with Seizure Frequency and Antiepileptic Drug Therapy
- 26 June 2019
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 56 (12) , 8392-8407
Abstract
Pharmacoresistance is a major clinical challenge for approximately 30% of patients with epilepsy. Previous studies indicate nuclear receptors (NRs), drug efflux transporters, and cytochrome P450 enzymes (CYPs) control drug passage across the blood-brain barrier (BBB) in drug-resistant epilepsy. Here, we (1) evaluate BBB changes, neurovascular nuclear receptors, and drug transporters in lesional/epileptic (EPI) and non-lesional/non-epileptic (NON-EPI) regions of the same brain, (2) examine regional CYP expression and activity, and (3) investigate the association among CYP brain expression, seizure frequency, duration of epilepsy, and antiepileptic drug (AED) combination. We used surgically resected brain specimens from patients with medically intractable epilepsy (n = 22) where the epileptogenic loci were well-characterized by invasive and non-invasive methods; histology confirmed distinction of small NON-EPI regions from EPI tissues. NRs, transporters, CYPs, and tight-junction proteins were assessed by western blots/immunohistochemistry, and CYP metabolic activity was determined and compared. The relationship of CYP expression with seizure frequency, duration of epilepsy, and prescribed AEDs was evaluated. Decreased BBB tight-junction proteins accompanied IgG leakage in EPI regions and correlated with upregulated NR and efflux transporter levels. CYP expression and activity significantly increased in EPI compared to NON-EPI tissues. Change in EPI and NON-EPI CYP3A4 expression increased in patients taking AEDs that were CYP substrates, was downregulated when CYP- and non-CYP-substrate AEDs were given together, and correlated with seizure frequency. Our studies suggest focal neurovascular CYP-NR-transporter alterations, as demonstrated by the relationship of seizure frequency and AED combination to brain CYP3A4, might together impact biotransformation machinery of human pharmacoresistant epilepsy.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke/National Institutes of Health (R01NS078307)
- National Institute of Neurological Disorders and Stroke/National Institutes of Health (R01NS095825)
- Brain and Behavior Research Foundation (18815)
- American Heart Association (13SDG13950015)
- Alternatives Research & Development Foundation (ARDF1508CG)
This publication has 46 references indexed in Scilit:
- TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissueSeizure: European Journal of Epilepsy, 2013
- Ogniskowa dysplazja korowa – stan obecny wiedzyPolish Journal of Radiology, 2012
- Treating patients with medically resistant epilepsyNeurology Clinical Practice, 2011
- Cellular localization and functional significance of CYP3A4 in the human epileptic brainEpilepsia, 2011
- Pattern of P450 expression at the human blood–brain barrier: Roles of epileptic condition and laminar flowEpilepsia, 2010
- High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsyEpilepsia, 2009
- Blood–brain barrier damage and brain penetration of antiepileptic drugs: Role of serum proteins and brain edemaEpilepsia, 2009
- EROD and MROD as Markers of Cytochrome P450 1A Activities in Hepatic Microsomes from Entire and Castrated Male PigsSensors, 2009
- ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrierJournal of Neurochemistry, 2008
- Clinically Significant Pharmacokinetic Drug Interactions with CarbamazepineClinical Pharmacokinetics, 1996